← SynDRA

BIMIRALISIB

SynDRA canonical compound SYN0039264 — structure-anchored drug synonym record

All known targets

• MTOR
• PIK3CB
• PIK3CG
• PIK3CA
• PIK3CD

Mechanisms of action (all sources)

• MTOR inhibitor
• PIK3CA INHIBITOR
• PIK3CB INHIBITOR
• PIK3CD INHIBITOR
• PIK3CG INHIBITOR
• PI3K inhibitor

Cross-references

• PubChem CID: 58507717
• ChEMBL: CHEMBL4084907
• DrugBank: DB14846
• KEGG: D11440
• PDB: A3W
• TTD: D0TU7B

Synonyms

• PQR309
• NC-B5
• NCB5
• PI3K-IN-2
• PQR-309
• UNII-6Z3QHB00LB
• 6Z3QHB00LB
• 5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine
• 5-[bis(morpholin-4-yl)-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine
• 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine
• Bimiralisib [INN]
• Bimiralisib [USAN]
• Bimiralisib [WHO-DD]
• SCHEMBL1309049
• GTPL8383
• Bimiralisib free base
• ADGGYDAFIHSYFI-UHFFFAOYSA-N
• EX-A2018
• BCP15887
• PQR-309(PI3K-IN-2)
• PQR 309
• bimiralisibum
• RefChem:1079871
• MFCD28902193
• Bimiralisib (PQR309)
• PQR309; Bimiralisib
• PQR-309(Bimiralisib)
• Bimiralisib (USAN/INN)
• PQR-309(Bimiralisib)?
• orb1305862
• PQR309; Bimiralisib free base
• SCHEMBL29352266
• C17H20F3N7O2
• Bimiralisib [USAN:INN:WHO-DD]
• GLXC-90536
• BDBM50240975
• NSC785117
• s8738
• AKOS027439949